Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study
Expanded access is currently available for this treatment.
|Conditions||abdominal aortic aneurysms, aorto-iliac aneurysms, juxtarenal aneurysms|
|Treatment||zenith® fenestrated aaa endovascular graft|
|Start date||May 2010|
|End date||November 2012|
|Trial identifier||NCT02577562, 04-541 CA|
The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Overall contact||Josephat Asiago|
Male or female participants at least 18 years old.
Inclusion Criteria: - Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm Exclusion Criteria: - Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal - Renal artery stenosis greater than 50 percent
|Official title||Zenith® Fenestrated AAA Endovascular Graft Clinical Study|
Call for more information